Posted October 16, 2017
Because Alzheimer’s disease causes abnormal deposits of amyloid beta protein and tau protein in the brain, researchers focused on how the proteins attack the brain. What they found may help drug companies to develop medications that will prevent the proteins from changing and therefore beginning the process of Alzheimer’s. Read more.